Karyopharm Therapeut (KPTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 88,399 | 129,975 | 118,021 | 69,197 | 49,663 |
| Marketable Securities | 163,322 | 133,098 | 210,178 | 77,472 | 79,889 |
| Receivables | 12,881 | 7,862 | N/A | N/A | N/A |
| Inventories | 2,644 | 346 | N/A | N/A | N/A |
| TOTAL | $276,531 | $278,570 | $334,612 | $148,423 | $131,636 |
| Non-Current Assets | |||||
| PPE Net | 2,219 | 3,046 | 3,863 | 2,185 | 2,836 |
| Investments And Advances | 24,215 | 2,016 | 2,001 | 29,396 | 45,434 |
| Other Non-Current Assets | 10,085 | 11,331 | 716 | 290 | 479 |
| TOTAL | $36,519 | $16,393 | $6,580 | $31,871 | $48,749 |
| Total Assets | $313,050 | $294,963 | $341,192 | $180,294 | $180,385 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,450 | 985 | 4,332 | 5,665 | 4,751 |
| Accrued Expenses | 52,930 | 40,878 | 32,493 | 21,445 | 11,362 |
| Other current liabilities | 609 | 500 | 327 | 133 | 83 |
| TOTAL | $60,203 | $46,350 | $46,904 | $49,467 | $16,476 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 297 | 2,341 | 9,752 | 22,224 | 280 |
| Other Non-Current Liabilities | 202,301 | 196,647 | 102,664 | 0 | 0 |
| TOTAL | $202,301 | $198,839 | $111,118 | $1,363 | $1,666 |
| Total Liabilities | $262,504 | $245,189 | $158,022 | $50,830 | $18,142 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,978 | 4,372 | 4,059 | 3,312 | 2,795 |
| Common Shares | 7 | 7 | 6 | 5 | 4 |
| Retained earnings | -1,069,611 | -873,338 | -673,748 | -495,341 | -366,104 |
| Other shareholders' equity | 518 | -37 | -244 | -217 | -274 |
| TOTAL | $50,546 | $49,774 | $183,170 | $129,464 | $162,243 |
| Total Liabilities And Equity | $313,050 | $294,963 | $341,192 | $180,294 | $180,385 |